Bone Loss Drugs Increase Stroke Risk in Patients With Cancer

Publication
Article
Oncology Nursing NewsDecember 2010
Volume 4
Issue 6

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Articles in this issue
Net Guides: Melanoma
Net Guides: Bone Metastases
Yoga for Cancer Care
FDA Updates
The Future of Nursing
Net Guides: Liver Cancer
Net Guides: Carcinoma of Unknown Primary Orgin
Tools to Help Patients Navigate Their Treatment Path
John Theurer Cancer Center Opens New Comprehensive Facility
Bone Loss Drugs Increase Stroke Risk in Patients With Cancer
Oncology Community Facing Severe Drug Shortages
Net Guides: Oral Cancer

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Image of a woman with gray hair on a light blue background
Photo of a man wearing scrubs in front of a blue background
Related Content
Graphic of myeloma cells

Q&A: Subcutaneous Daratumumab Eases Myeloma Time Burden

Bridget Hoyt
June 25th 2025
Article

Subcutaneous daratumumab makes it easier for patients to find appointments that fit with their lifestyles and schedules, according to Gina Fries, PA-C.

Magazine page with Rx Road Map for Durvalumab for Non-Small Cell Lung Cancer

Rx Road Map: Durvalumab for Non-Small Cell Lung Cancer

Stacey Hield, BSN, RN, OCN
June 19th 2025
Article

Read Stacey Hield, BSN, RN, OCN's recommendations for the best use of durvalumab in non–small cell lung cancer.

Photo of two women smiling with their arms around each other, one with a headwrap

No One Should Face Cancer Alone: The Power of Community in Cancer Care

Marissa Fors LCSW, OSW-C, CCM
June 18th 2025
Article

Ask patients, "Who's in your corner?"

Photo of a nurse recording data on a computer and tablet

The Evolving Role of the Oncology Nurse in Clinical Trials

Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN
June 14th 2025
Article

Oncology nurses are paramount to the treatment success of patients, especially through their work on clinical trials.

Photo of an APP talking to and empowering a patient

Case Study: Bridging the Gap for Patients With Metastatic CRC

Randi Kihnel, MSN, APRN, ACCNS-AG
June 13th 2025
Article

Advanced practice providers have the opportunity to instill hope in patients through education and personalized care.

PDF of Rx Road Map for subcutaneous daratumumab in multiple myeloma

Rx Road Map: Subcutaneous Daratumumab in Multiple Myeloma

Sylwia Zielinska, RN
Published: May 7th 2025 | Updated: June 5th 2025
Article

A registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.